TrademarkDir
VDI/REP-PHARM HEALTHCARE LOGISTICS
DEAD

Serial Number

76123051

Owner

REP-PHARM INC.

Attorney

MARK B EISEN

Filing Date

Sep 6, 2000

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

VDI/REP-PHARM HEALTHCARE LOGISTICS Trademark

Serial Number: 76123051

VDI/REP-PHARM HEALTHCARE LOGISTICS is a trademark filed by REP-PHARM INC. on September 6, 2000. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

REP-PHARM INC. (2 trademarks)

1041 North Service Road East, Suite 200
Oakville, Ontario L6H 1A6 , CA

Entity Type: 03

Trademark Details

Filing Date

September 6, 2000

Registration Date

Not Registered

Published for Opposition

September 16, 2003

Goods & Services

Wholesale distributorships featuring pharmaceuticals and pharmaceutical products; and management of inventory, and accounts receivable services provided to manufacturers and importers of pharmaceuticals and pharmaceutical products

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Aug 12, 2004 ABN6
CASE FILE IN TICRS
Jun 7, 2004 CFIT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2003 NOAM
PUBLISHED FOR OPPOSITION
Sep 16, 2003 PUBO
NOTICE OF PUBLICATION
Aug 27, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Jul 9, 2003 CNEA
ASSIGNED TO EXAMINER
Jun 20, 2003 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 20, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2003 CRFA
PAPER RECEIVED
Feb 7, 2003 MAIL
LETTER OF SUSPENSION MAILED
Sep 13, 2002 CNSL
PREVIOUS ACTION COUNT WITHDRAWN
Jul 3, 2002 ZZZY
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2002 CRFA
ASSIGNED TO EXAMINER
May 1, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2002 CRFA
NON-FINAL ACTION MAILED
Feb 1, 2001 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2001 DOCK
ASSIGNED TO EXAMINER
Jan 23, 2001 DOCK

Related Trademarks

More from this Owner

REP-PHARM

REP-PHARM

REP-PHARM

REP-PHARM

REP-PHARM

REP-PHARM